Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever

International Journal of Medical Microbiology

Volumn 301, Issue 4, 2011, Pages 359-364

  Martins, Flaviano S ^a   Elian, Samir D A ^a   Vieira, Angélica T ^a   Tiago, Fabiana C P ^a   Martins, Ariane K S ^a   Silva, Flávia C P ^a   Souza, Éricka L S ^a   Sousa, Lirlândia P ^a   Araújo, Helena R C ^b   Pimenta, Paulo F ^b   Bonjardim, Cláudio A ^a   Arantes, Rosa M E ^a   Teixeira, Mauro M ^a   Nicoli, Jacques R ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

AP 1; Cytokines; MAP kinases; NF B; Probiotics; Saccharomyces cerevisiae; Salmonella enterica serovar Typhimurium

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROBIOTIC AGENT; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG BINDING; FUNGAL STRAIN; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; SACCHAROMYCES CEREVISIAE; SALMONELLA ENTERICA; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TYPHOID FEVER; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; INFLAMMATION; MICE; PROBIOTICS; SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TYPHOID FEVER;

EID: 79952705245     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2010.11.002     Document Type: Article

References (36)

1. Ciriello C.J., Lachance M.A. YEASTCOMPARE 2001, University of Western Ontario, London, ON, Canada.
2. Coburn B., Grassl G.A., Finlay B.B. Salmonella, the host and disease: a brief review. Immunol. Cell Biol. 2007, 85:112-118.
3. Collazo C., Galán J.E. The invasion-associated type-III protein secretion system in Salmonella - a review. Gene 1996, 192:51-59.
4. Crump J.A., Luby S.P., Mintz E.D. The global burden of typhoid fever. Bull. World Health Org. 2004, 82:346-353.
5. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983, 11. 1475-1189.
6. Eckmann L., Kagnoff M.F. Cytokines in host defense against Salmonella. Microb. Infect. 2001, 3:1191-1200.
7. Eisenstein T.K. Mucosal immune defense: the Salmonella typhimurium model. Intracellular Bacterial Vaccine Vectors 1999, 51-109. Willey-Liss, New York. Y. Paterson (Ed.).
8. FAO/WHO Working Group, Guidelines for the Evaluation of Probiotics in Food 2002, FAO/WHO, London, ON, Canada.
9. Galán J.E., Collmer A. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 1999, 284:1322-1328.
10. Galán J.E., Bliska J.B. Cross-talk between bacterial pathogens and their host cells. Annu. Rev. Cell. Dev. Biol. 1996, 12:221-255.
11. Gedek B.R. Adherence of Escherichia coli serogroup O157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 1999, 42:261-264.
12. Generoso S.V., Viana M., Santos R., Martins F.S., Machado J.A., Arantes R.M., Nicoli J.R., Correia M.I., Cardoso V.N. Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch. Microbiol. 2010, 192:477-484.
13. Hobbie S., Chen L.M., Davis R.J., Galán J.E. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J. Immunol. 1997, 159:5550-5559.
14. Hoffmann E., Dittrich-Breiholz O., Holtmann H., Kracht M. Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 2002, 72:847-855.
15. Jain S., Yadav H., Sinha P.R. Probiotic dahi containing Lactobacillus casei protects against Salmonella enteritidis infection and modulates immune response in mice. J. Med. Food 2009, 12:576-583.
16. Jain S., Yadav H., Sinha P.R., Naito Y., Marotta F. Dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei has a protective effect against Salmonella enteritidis infection in mice. Int. J. Immunopathol. Pharmacol. 2008, 21:1021-1029.
17. Jawhara S., Poulain D. Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. Med. Mycol. 2007, 45:691-700.
18. Kagnoff M.F., Eckmann L. Epithelial cells as sensors for microbial infection. J. Clin. Invest. 1997, 100:6-10.
19. Kornonen T.K., Leffler H., Svanborg Eden C. Binding specificity of piliated strains of Escherichia coli and Salmonella typhimurium to epithelial cells Saccharomyces cerevisiae cells, and erythrocytes. Infect. Immun. 1981, 32:796-804.
20. Martins F.S., Nardi R.M.D., Arantes R.M.E., Rosa C.A., Neves M.J., Nicoli J.R. Screening of yeast as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. J. Gen. Appl. Microbiol. 2005, 51:83-92.
21. Martins F.S., Rodrigues A.C.P., Tiago F.C.P., Penna F.J., Rosa C.A., Arantes R.M.E., Nardi R.M.D., Neves M.J., Nicoli J.R. Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J. Med. Microbiol. 2007, 56:352-359.
22. Martins F.S., Veloso L.C., Arantes R.M., Nicoli J.R. Effects of yeast probiotic formulation on viability, revival and protection against infection with Salmonella enterica ssp. enterica serovar Typhimurium in mice. Lett. Appl. Microbiol. 2009, 49:738-744.
23. Martins F.S., Dalmasso G., Arantes R.M.E., Doye A., Lemichez E., Lagadec P., Imbert V., Peyron J.F., Rampal P., Nicoli J.R., Czerucka D. Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection. Plos One 2010, 5:e8925.
24. National Research Council Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
25. Perez-Sotelo L.S., Talavera-Rojas M., Monroy-Salazar H.G., Lagunas-Bernabe S., Cuaron-Ibarguengoytia J.A., Jimenez R.M., Vazquez-Chagoyan J.C. In vitro evaluation of the binding capacity of Saccharomyces cerevisiae Sc47 to adhere to the wall of Salmonella spp. Rev. Latinoam. Microbiol. 2005, 47:70-75.
26. Pimenta P.F., De Souza W. Fine structure and cytochemistry of the endoplasmic reticulum and its association with the plasma membrane of Leishmania mexicana amazonensis. J. Submicrosc. Cytol. 1985, 17:413-419.
27. Pleasants J.R. Gnotobiotics. Handbook of Laboratory Animal Science 1974, 119-174. CRC Press, Cleveland. E.C. Melby, N.H. Altmann (Eds.).
28. Reiff C., Kelly D. Inflammatory bowel disease, gut bacteria and probiotic therapy. Int. J. Med. Microbiol. 2010, 300:25-33.
29. Santos R.L., Zhang S., Tsolis R.M., Kingsley R.A., Adams L.G., Bäumler A.J. Animal models of Salmonella infections: enteritis versus typhoid fever. Microb. Infect. 2001, 3:1335-1344.
30. Sousa L.P., Brasil B.S., Silva B.M., Freitas M.H., Nogueira S.V., Ferreira P.C., Kroon E.G., Bonjardim C.A. Plasminogen/plasmin regulates alpha-enolase expression through the MEK/ERK pathway. Biochem. Biophys. Res. Commun. 2005, 329:237-245.
31. Souza D.G., Vieira A.T., Soares A.C., Pinho V., Nicoli J.R., Vieira L.Q., Teixeira M.M. The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J. Immunol. 2004, 173:4137-4146.
32. Souza D.G., Amaral F.A., Fagundes C.T., Coelho F.M., Arantes R.M., Sousa L.P., Matzuk M.M., Garlanda C., Mantovani A., Dias A.A., Teixeira M.M. The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice. Am. J. Pathol. 2009, 174:1309-1318.
33. Truusalu K., Mikelsaar R.H., Naaber P., Karki T., Kullisaar T., Zilmer M., Mikelsaar M. Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin. BMC Microbiol. 2008, 8:132.
34. Vieira L.Q., dos Santos L.M., Neumann E., da Silva A.P., Moura L.N., Nicoli J.R. Probiotics protect mice against experimental infections. J. Clin. Gastroenterol. 2008, 42:S168-169.
35. Wohlgemuth S., Loh G., Blaut M. Recent developments and perspectives in the investigation of probiotic effects. Int. J. Med. Microbiol. 2010, 300:3-10.
36. Zaharik M.L., Gruenheid S., Perrin A.J., Finlay B.B. Delivery of dangerous goods: Type III secretion in enteric pathogens. Int. J. Med. Microbiol. 2002, 291:593-603.